Research analysts at StockNews.com began coverage on shares of 22nd Century Group (NASDAQ:XXII – Get Free Report) in a report issued on Monday. The firm set a “sell” rating on the biotechnology company’s stock.
22nd Century Group Trading Down 4.9 %
Shares of XXII stock opened at $0.09 on Monday. The company has a 50-day moving average of $0.15 and a two-hundred day moving average of $0.55. The company has a debt-to-equity ratio of 1.59, a current ratio of 1.09 and a quick ratio of 0.93. 22nd Century Group has a 1-year low of $0.08 and a 1-year high of $5.28. The firm has a market cap of $4.36 million, a PE ratio of 0.00 and a beta of 1.45.
22nd Century Group (NASDAQ:XXII – Get Free Report) last announced its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($0.54) earnings per share for the quarter. 22nd Century Group had a negative net margin of 144.09% and a negative return on equity of 380.39%. The business had revenue of $5.95 million during the quarter.
Institutional Trading of 22nd Century Group
About 22nd Century Group
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
See Also
- Five stocks we like better than 22nd Century Group
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Disney’s Magic Strategy: Reinventing the House of Mouse
- How to buy stock: A step-by-step guide for beginners
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- Stock Dividend Cuts Happen Are You Ready?
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.